Top
image: C. CIANCIARUSO/I. KEKLIKOGLOU/EPFL

Study uncovers how tumors backfire on neoadjuvant chemotherapy

January 2, 2019

Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called ‘neoadjuvant’ therapy, helps to reduce the size of the tumor to facilitate breast-conserving surgery, and can even eradicate the tumor, leaving few or no cancerous cells for the surgeon to remove. In those cases, the patients are very likely to remain cancer-free for life after surgery.

Read More on The Medical News